FrancophonIA/ELRC3.0 huggingface dataset:
English: Abseamed can only be obtained with a prescription and treatment must be started under the supervision of a doctor who has experience in the management of patients with the conditions that Abseamed is used for.
Slovenian: Predpisovanje in izdaja zdravila Abseamed je le na recept, zdravljenje z njim pa se lahko uvede le pod nadzorom zdravnika, ki ima izkušnje z zdravljenjem bolnikov z boleznimi, za katere se to zdravilo uporablja.
English: Because Abseamed is a biosimilar medicine, the studies on effectiveness and safety of epoetin alfa carried out with Eprex/Erypo do not all need to be repeated for Abseamed.
Slovenian: Ker je zdravilo Abseamed podobno biološko zdravilo, študij o učinkovitosti in varnosti učinkovine epoetin alfa, ki so že bile izvedene z zdravilom Eprex/Erypo, za zdravilo Abseamed ni treba ponavljati.
English: Abseamed is used when patients are at low or intermediate risk of developing acute myeloid leukaemia and have low levels of the natural hormone erythropoietin.
Slovenian: Zdravilo Abseamed se uporablja pri bolnikih, pri katerih obstaja majhno ali srednje tveganje za pojav akutne mieloične levkemije in ki imajo nizke ravni naravnega hormona eritropoetina.
English: The reference medicine for Abseamed is Eprex/Erypo.
Slovenian: Referenčno zdravilo za zdravilo Abseamed je zdravilo Eprex/Erypo.
English: All of the patients had been receiving Eprex/Erypo injected into a vein for at least 8 weeks before they were either switched to Abseamed or remained on Eprex/Erypo.
Slovenian: Vsem bolnikom so zdravilo Eprex/Erypo najmanj osem tednov injicirali v veno, preden so bodisi začeli prejemati zdravilo Abseamed bodisi so še naprej prejemali zdravilo Eprex/Erypo.
English: Abseamed is available in pre-filled syringes of various strengths and is given as an injection into a vein or as an injection under the skin, depending on the condition for which the patient is being treated.
Slovenian: Zdravilo Abseamed je na voljo v napolnjenih injekcijskih brizgah različnih jakosti in se daje z injiciranjem v veno ali podkožje, kar je odvisno od bolezenskega stanja bolnika, ki se zdravi.
English: • to treat anaemia in adults with myelodysplastic syndromes (conditions in which the production of healthy blood cells is defective).
Slovenian: • za zdravljenje anemije pri odraslih z mielodisplastičnimi sindromi (obolenji, pri katerih je okvarjeno nastajanje zdravih krvnih celic).
English: The injection under the skin may be given by the patient or their carer if they have been appropriately trained.
Slovenian: Bolnik si zdravilo lahko v podkožje injicira sam ali mu ga injicira negovalec, če sta bila za to ustrezno usposobljena.
English: Therefore the Agency's view was that, as for Eprex/Erypo, the benefit of Abseamed outweighs the identified risk and it can be authorised.
Slovenian: Agencija je zato menila, da koristi zdravila Abseamed enako kot pri zdravilu Eprex/Erypo odtehtajo znana tveganja in da se zdravilo lahko odobri.
English: The European Medicines Agency decided that, in accordance with EU requirements for biosimilar medicines, Abseamed has a highly similar structure, purity and biological activity to Eprex/Erypo and is distributed in the body in the same way.
Slovenian: Evropska agencija za zdravila je zaključila, da je bilo v skladu z zahtevami EU glede podobnih bioloških zdravil dokazano, da je zdravilo Abseamed po zgradbi, čistosti in biološkem delovanju primerljivo zdravilu Eprex/Erypo in da se po telesu enako prenaša.
English: Patients switching to Abseamed maintained haemoglobin levels to the same extent as those continuing with Eprex/Erypo.
Slovenian: Bolniki, ki so prešli na jemanje zdravila Abseamed, so ohranili vrednost hemoglobina na enaki ravni kot bolniki, ki so nadaljevali zdravljenje z zdravilom Eprex/Erypo.
English: How is Abseamed used?
Slovenian: Kako se zdravilo Abseamed uporablja?
English: Laboratory studies comparing Abseamed with the reference medicine Eprex/Erypo have shown that the active substance in Abseamed is highly similar to that in Eprex/Erypo in terms of structure, purity and biological activity.
Slovenian: Laboratorijske študije, v katerih so zdravilo Abseamed primerjali z referenčnim zdravilom Eprex/Erypo, so pokazale, da je učinkovina v zdravilu Abseamed po zgradbi, čistosti in biološkem delovanju zelo podobna učinkovini v zdravilu Eprex/Erypo.
English: • to reduce the need for blood transfusions in adults with moderate anaemia who are about to undergo major orthopaedic (bone) surgery, such as hip surgery.
Slovenian: • za zmanjšanje potrebe po transfuziji krvi pri odraslih z blago obliko anemije pred zahtevnejšim ortopedskim kirurškim posegom (na kosteh), na primer operacijo kolkov.
English: • patients who have developed pure red cell aplasia (reduced or stopped red blood cell production)
Slovenian: (zmanjšano ali zaustavljeno tvorjenje rdečih krvnih celic);
English: For the full list of side effects of Abseamed, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Abseamed, glejte navodilo za uporabo.
English: In addition, studies have shown that the effects of the medicine are equivalent to those of Eprex/Erypo in increasing and maintaining blood cell counts in patients with chronic kidney failure or undergoing chemotherapy.
Slovenian: Poleg tega so študije pokazale, da so učinki tega zdravila pri zviševanju in ohranjanju števila rdečih krvnih celic pri bolnikih s kronično odpovedjo ledvic ali tistih, ki prejemajo kemoterapijo, enakovredni učinkom zdravila Eprex/Erypo.
English: Abseamed, injected into a vein, was compared with the reference medicine in one main study involving 479 patients with anaemia caused by kidney problems.
Slovenian: V eni glavni študiji, ki je vključevala 479 bolnikov z anemijo, povezano z obolenjem ledvic, so zdravilo Abseamed, injicirano v veno, primerjali z referenčnim zdravilom.
English: Studies have also shown that giving Abseamed produces similar levels of the active substance in the body to giving Eprex/Erypo.
Slovenian: Študije so pokazale tudi, da zdravilo Abseamed vzpostavi podobne ravni učinkovine v telesu kot zdravilo Eprex/Erypo.
English: A further study showed that Abseamed was safe and effective when given under the skin in 416 patients with chronic kidney failure.
Slovenian: V dodatni študiji so pri 416 bolnikih s kronično odpovedjo ledvic dokazali, da je zdravilo Abseamed pri injiciranju v podkožje varno in učinkovito.
English: In addition, Abseamed was shown to be as effective as Eprex/Erypo at increasing and maintaining red blood cell counts in several studies.
Slovenian: Poleg tega so v več študijah dokazali, da je zdravilo Abseamed pri zviševanju in ohranjanju števila rdečih krvnih celic enako učinkovito kot zdravilo Eprex/Erypo.
English: Another study showed that Abseamed injected under the skin was as effective in maintaining haemoglobin levels as Eprex/Erypo in 114 cancer patients who were receiving chemotherapy.
Slovenian: Druga študija pri 114 bolnikih z rakavimi obolenji, ki so prejemali kemoterapijo, je pokazala, da je bilo zdravilo Abseamed, injicirano v podkožje, enako učinkovito pri ohranjanju ravni hemoglobina kot zdravilo Eprex/Erypo.
English: How does Abseamed work?
Slovenian: Kako zdravilo Abseamed deluje?
English: Vial (type I glass) closed with a halogenobutyl rubber stopper and aluminium cap
Slovenian: Intramuskularno Viala (steklo tipa I) zaprta z zamaškom iz halogenobutilne gume in aluminijasto zaporko
English: --1 Equine influenza virus strains: A/equine-2/South Africa/4/03 strain
Slovenian: --1 Seva virusa influence konj: A/konjski-2/Južna Afrika/4/03 50 AU/ml A/konjski-2/ Newmarket/2/93 50 AU/ml Toksoid tetanusa
English: 40 Lf/ml
Slovenian: 40 Lf2
English: 1 dose 10 glass vials
Slovenian: 1 odmerek 10 steklenih vial Nič dni
English: Tetanus toxoid
Slovenian: Karenca
English: List of the names, pharmaceutical form, strength of the medicinal product, route of administration, applicant / marketing authorisation holder in the Member States
Slovenian: Seznam imen, farmacevtske oblike, jakosti zdravila, načina uporabe, predlagatelja, imetnika dovoljenja za promet z zdravilom v državah članicah
English: Ireland Pinewood Laboratories Limited, Ballmacarbry, Clonmel, Co.
Slovenian: Laboratories Limited, Ballmacarbry, Clonmel, Co.
English: The application was submitted to Ireland as reference Member State and Austria, Bulgaria, Denmark, Spain, Finland, France, Hungary, the Netherlands, Poland, Portugal, Romania, Sweden, Slovenia as concerned Member States, as well as Iceland and Norway.
Slovenian: Vloga je bila predložena Irski kot referenčni državi članici in Avstriji, Bolgariji, Danski, Španiji, Finski, Franciji, Madžarski, Nizozemski, Poljski, Portugalski, Romuniji, Švedski ter Sloveniji kot zadevnim državam članicam ter Islandiji in Norveški.
English: The final opinion was converted into a Decision by the European Commission on 25 May 2012.
Slovenian: Končno mnenje je bilo spremenjeno v Odločbo Evropske komisije dne 25. maja 2012.
English: The applicant, Pfizer Limited, has submitted an application for a decentralised procedure for the above mentioned veterinary medicinal product in the framework of Article 32 of Directive 2001/82/EC, as amended.
Slovenian: Predlagatelj, družba Pfizer Limited, je predložil vlogo za začetek decentraliziranega postopka za zgoraj omenjeno zdravilo za uporabo v veterinarski medicini v okviru člena 32 Direktive 2001/82/ES, kakor je bila spremenjena.
English: Doramectin is a macrocyclic lactone and is closely related to ivermectin.
Slovenian: Doramektin je makrociklični lakton in je zelo soroden ivermektinu.
English: Potential serious risks were identified during the decentralised procedure by two concerned Member States regarding the environmental risk assessment (the Netherlands and France).
Slovenian: V okviru decentraliziranega postopka sta dve zadevni državi članici (Nizozemska in Francija) opredelili morebitna resna tveganja glede ocene tveganja za okolje.
English: Prontax 5 mg/ml pour-on solution for cattle (and associated names) contains doramectin.
Slovenian: Zdravilo Prontax 5 mg/ml kožni poliv, raztopina za govedo (in povezana imena) vsebuje doramektin.
English: Based on evaluation of the currently available data, the CVMP considered that the benefit-risk profile of Prontax 5 mg/ml pour-on solution for cattle and associated names is deemed to be positive provided that the recommended risk mitigation measures are added to the product information regarding risk to aquatic organisms and dung fauna.
Slovenian: Na podlagi ocene trenutno razpoložljivih podatkov je odbor CVMP presodil, da razmerje med koristmi in tveganji za zdravilo Prontax 5 mg/ml kožni poliv, raztopina za govedo, in povezana imena, velja za pozitivno, če so informacijam o zdravilu dodani priporočeni ukrepi za zmanjšanje tveganja v zvezi s
English: referral for Prontax 5 mg/ml pour-on solution for cattle and associated names
Slovenian: za zdravilo Prontax 5 mg/ml kožni poliv, raztopina za govedo, in povezana imena
English: Opinion following an Article 33(4)F F referral for Prontax 5 mg/ml pour-on solution for cattle and associated names
Slovenian: Mnenje v zvezi z napotitvijo v skladu s členom 33(4)F F za zdravilo Prontax 5 mg/ml kožni poliv, raztopina za govedo, in povezana imena EMA/421650/2012
English: recommending the granting of a Marketing Authorisation for Prontax 5 mg/ml pour-on solution for cattle and associated names.
Slovenian: Odbor CVMP je zato 8. februarja2012 sprejel pozitivno mnenje, v katerem priporoča odobritev dovoljenja za promet z zdravilom Prontax 5 mg/ml kožni poliv, raztopina za govedo, in povezana imena.
English: The active substance in Pioglitazone Teva Generics, pioglitazone, makes cells (fat, muscle and liver) more sensitive to insulin, which means that the body makes better use of the insulin it produces.
Slovenian: Zdravilna učinkovina zdravila Pioglitazone Teva Generics, pioglitazon, poveča občutljivost celic (maščevja, mišic in jeter) za insulin, kar pomeni, da telo bolje izrablja insulin, ki ga proizvaja.
English: This means that Pioglitazone Teva Generics is similar to a ‘reference medicine' already authorised in the European Union (EU) called Actos.
Slovenian: To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Actos.
English: Pioglitazone Teva Generics was to be used to treat type 2 diabetes in adults, particularly those who are overweight.
Slovenian: Zdravilo Pioglitazone Teva Generics naj bi se uporabljalo za zdravljenje sladkorne bolezni tipa 2 pri odraslih, zlasti tistih s prekomerno telesno maso.
English: The CHMP concluded that, in accordance with EU requirements, Pioglitazone Teva Generics had been shown to have comparable quality and to be bioequivalent to Actos.
Slovenian: CHMP je zaključil, da je bilo v skladu z zahtevami EU dokazano, da ima zdravilo Pioglitazone Teva Generics primerljivo raven kakovosti kot zdravilo Actos ter da mu je biološko enakovredno.
English: On 26 January 2012, TEVA Generics B.V. officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Pioglitazone Teva Generics, for the treatment of type 2 diabetes.
Slovenian: je dne 26. januarja 2012 uradno obvestila Odbor za zdravila za uporabo v humani medicini (CHMP), da želi umakniti vlogo za pridobitev dovoljenja za promet z zdravilom Pioglitazone Teva Generics, namenjenim zdravljenju sladkorne bolezni tipa 2.
English: Because Pioglitazone Teva Generics is a generic medicine, studies in patients have been limited to tests to determine that it is bioequivalent to the reference medicine, Actos.
Slovenian: Ker je zdravilo Pioglitazone Teva Generics generično zdravilo, so bile študije pri bolnikih omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu Actos.
English: Pioglitazone Teva Generics was developed as a ‘generic medicine'.
Slovenian: Zdravilo Pioglitazone Teva Generics je bilo razvito kot „generično zdravilo“.
English: Therefore, at the time of the withdrawal, the CHMP had given a positive opinion, recommending that a marketing authorisation be granted for Pioglitazone Teva Generics for the treatment of type 2 diabetes.
Slovenian: Odbor je zato v času umika vloge izrazil pozitivno mnenje in priporočil odobritev vloge za pridobitev dovoljenja za promet z zdravilom Pioglitazone Teva Generics za zdravljenje sladkorne bolezni tipa 2.
English: Pioglitazone Teva Generics is a medicine that contains the active substance pioglitazone.
Slovenian: Pioglitazone Teva Generics je zdravilo, ki vsebuje zdravilno učinkovino pioglitazon.
English: Pioglitazone Teva Generics was to used on its own in patients for whom metformin (another antidiabetes medicine) is not suitable.
Slovenian: Prav tako naj bi se uporabljalo samostojno pri bolnikih, za katere metformin (drugo zdravilo proti sladkorni bolezni) ni primeren.
English: What is Pioglitazone Teva Generics?
Slovenian: Kaj je zdravilo Pioglitazone Teva Generics?
English: Pioglitazone Teva Generics was also to be used in combination with metformin in patients who are not satisfactorily controlled on metformin alone.
Slovenian: Uporabljalo naj bi se tudi v kombinaciji z metforminom pri bolnikih, pri katerih zgolj z metforminom ni mogoče doseči zadovoljivega nadzora.
English: Pioglitazone Teva Generics was also to be used together with insulin in patients who are not satisfactorily controlled with insulin alone and cannot take metformin.
Slovenian: Uporabljalo naj bi se tudi skupaj z insulinom pri bolnikih, pri katerih bolezen ni zadostno nadzorovana samo z insulinom in za katere metformin ni primeren.
English: How is Pioglitazone Teva Generics expected to work?
Slovenian: Kako naj bi zdravilo Pioglitazone Teva Generics delovalo?
English: What was Pioglitazone Teva Generics expected to be used for?
Slovenian: Za kaj naj bi se zdravilo Pioglitazone Teva Generics uporabljalo?
English: o Your doctor will tell you if you need an observer for longer than 6 months.
Slovenian: o Zdravnik vam bo povedal, ali potrebujete opazovalca več kot 6 mesecev.
English: An observer is someone who:
Slovenian: Opazovalec je oseba, ki
English: BEFORE YOU START
Slovenian: PRED ZAČETKOM
English: Most people respond within 18 months, but it can sometimes take up to 30 months.
Slovenian: Pri večini ljudi do odziva pride v 18 mesecih, vendar lahko včasih traja do 30 mesecev.
English: A risk to infants cannot be excluded.
Slovenian: Tveganja za dojenčke ni mogoče izključiti.
English: The time to reach a response ranged from 0.5 to 30 months.
Slovenian: Čas za doseganje odziva je znašal od 0,5 do 30 mesecev.
English: Prior to independent self-injection, a healthcare professional should:
Slovenian: Pred samostojnim samoinjiciranjem mora zdravstveni delavec:
English: No differences in the safety profile were observed.
Slovenian: Ni bilo opaženih razlik v varnostnem profilu.
English: • Each day, change (rotate) your injection sites.
Slovenian: • Vsak dan spremenite (menjajte) mesta vbrizgavanja.
English: Study 302: Efficacy assessment
Slovenian: Študija 302: ocenjevanje učinkovitosti
English: Individual values for half-life range from 14 to 132 hours.
Slovenian: Posamezne vrednosti razpolovnega časa znašajo od 14 do 132 ur.
English: The clinical significance of these findings and functional consequences are unknown.
Slovenian: Klinična pomembnost teh ugotovitev in funkcijske posledice niso znane.
English: Keep it with you at all times.
Slovenian: Vedno ga imejte pri sebi.
English: Tell your doctor that you had a severe allergic reaction.
Slovenian: Zdravniku povejte, da ste imeli hudo alergijsko reakcijo.
English: Some of these allergic reactions can be more serious, as described below, and will require immediate attention.
Slovenian: Nekatere alergijske reakcije so lahko resnejše, kot je opisano spodaj, in zahtevajo takojšnje ukrepanje.
English: The absolute bioavailability in humans is unknown.
Slovenian: Absolutna biološka uporabnost pri ljudeh ni znana.
English: The effects in offspring were associated with maternal toxicity.
Slovenian: Učinki pri mladičih so bili povezani s toksičnostjo pri materi.
English: These medicines help to reduce the symptoms of an allergic reaction.
Slovenian: Ta zdravila pripomorejo k zmanjšanju simptomov alergijske reakcije.
English: Currently available data on patients aged 16 up to 18 years are described in section 4.8 and 5.1.
Slovenian: Trenutno razpoložljivi podatki za bolnike, stare od 16 do 18 let, so opisani v poglavjih 4.8 in 5.1.
English: There may be new information.
Slovenian: Morda bodo vključevala nove informacije.
English: The recommended injection sites are:
Slovenian: Priporočeni mesti vbrizgavanja sta:
English: No vacuolation was observed in the brain.
Slovenian: Vakuolizacija ni bila opažena v možganih.
English: Dose titration and time to achieve response
Slovenian: Titracija odmerka in čas, potreben za doseganje odziva
English: Study 301: Treatment initiation (Induction and Titration)
Slovenian: Študija 301: začetek zdravljenja (indukcija in titracija)
English: If you miss a dose, take your next dose at the regular time.
Slovenian: Če odmerka niste vzeli, naslednji odmerek vzemite ob običajnem času.
English: The immune response stabilises over 6 to 9 months of total treatment.
Slovenian: Imunski odziv se stabilizira v 6-9 mesecih celotnega zdravljenja.
English: Do not use a microwave and do not place in hot water.
Slovenian: Ne uporabite mikrovalovne pečice in ne potopite je v vročo vodo.
English: Table 1: Recommended dosing regimen
Slovenian: Tabela 1: Priporočeni režim odmerjanja
English: Duration prior to next dose increase
Slovenian: Čas do naslednjega povečanja odmerka
English: Seven out of the 16 patients discontinued treatment.
Slovenian: Sedem od 16 bolnikov se je prenehalo zdraviti.
English: Overall treatment experience from Study 301 and Study 302
Slovenian: Skupna izkušnja z zdravljenjem v študiji 301 in študiji 302
English: • Do not touch the cleaned injection site.
Slovenian: • Ne dotikajte se očiščenega mesta vbrizgavanja.
English: Step 8: Clean the chosen site with an alcohol pad.
Slovenian: 8. korak: Izbrano mesto očistite z alkoholno krpico.
English: Step 1: Collect supplies:
Slovenian: 1. korak: Zberite pripomočke:
English: Symptoms of inattention and mood were also evaluated during this period.
Slovenian: V tem obdobju so se ocenjevali tudi simptomi, povezani z nepozornostjo in razpoloženjem.
English: Serious side effects include:
Slovenian: Resni neželeni učinki so med drugim:
English: If your phenylalanine levels are too high or too low during pregnancy, this may harm you or your baby.
Slovenian: Če imate med nosečnostjo previsoke ali prenizke ravni fenilalanina, lahko to škoduje vam ali otroku.
English: Slowly increasing your dose over time allows your body to adjust to this medicine.
Slovenian: S počasnim postopnim povečevanjem odmerka se vaše telo lahko prilagodi na to zdravilo.
English: Osmolality: 260 - 290 mOsm/kg
Slovenian: Osmolalnost: 260-290 mOsm/kg
English: Efficacy results over time are presented in Table 4 and Figure 1.
Slovenian: Rezultati učinkovitosti glede na čas so predstavljeni v tabeli 4 in sliki 1.
English: Frequencies are defined as: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000) and not known (cannot be estimated from the available data).
Slovenian: Pogostnosti so opredeljene kot: zelo pogosti (≥ 1/10), pogosti (od ≥ 1/100 do < 1/10), občasni (od ≥ 1/1.000 do < 1/100), redki (od ≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000) in neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
English: Relatively low titres of IgE has also been observed.
Slovenian: Opaženi so bili tudi relativno nizki titri protiteles razreda IgE.
English: The majority of patients (66%) reached a response by 18 months of total treatment.
Slovenian: Pri večini bolnikov (66 %) je bil odziv dosežen v 18 mesecih celotnega zdravljenja.
English: Posology is the same in these patients as in adults.
Slovenian: Odmerjanje je pri teh bolnikih enako kot pri odraslih.
English: Monitoring of blood phenylalanine level is recommended once a month.
Slovenian: Spremljanje ravni fenilalanina v krvi se priporoča enkrat mesečno.
English: People who have PKU have high levels of phenylalanine and this can lead to serious health problems.
Slovenian: Ljudje s PKU imajo visoke ravni fenilalanina, kar lahko povzroči resne zdravstvene težave.
English: Based on its mechanism of action, pegvaliase is not expected to be tumorigenic.
Slovenian: Glede na mehanizem delovanja se ne pričakuje, da bi bila pegvaliaza tumorogena.
English: 6 Reflects high sensitivity CRP (hsCRP) levels above upper limit of normal (greater than 0.287 mg/dl) over a 6 month period.
Slovenian: 6 Predstavlja ravni CRP visoke občutljivosti (hs-CRP), višje od zgornje meje normalne vrednosti (več kot 0,287 mg/dl) v obdobju 6 mesecev.
English: An additional 7% of patients responded to Palynziq after 18 months of treatment.
Slovenian: Dodatnih 7 % bolnikov se je na zdravilo Palynziq odzvalo po 18 mesecih zdravljenja.
English: Patients should be instructed to pre-medicate with an H1-receptor antagonist, H2-receptor antagonist, and antipyretic.
Slovenian: Bolnikom je treba naročiti uporabo premedikacije z antagonistom receptorja H1, antagonistom receptorja H2 in antipiretikom.
English: Figure F Inject at least 5 cm apart
Slovenian: Slika F Vbrizgavajte vsaj 5 cm narazen
English: The potency of this medicinal product should not be compared to any other PEGylated or non-PEGylated protein of the same therapeutic class.
Slovenian: Jakost tega zdravila se ne sme primerjati s katero koli drugo pegilirano ali nepegilirano beljakovino iz iste terapevtske skupine.
English: Vacuoles in all tissues, with the exception of the kidney, resolved or were diminished by the end of the recovery period, suggesting partial reversibility.
Slovenian: Vakuole v vseh tkivih, razen v ledvicah, so se do konca obdobja okrevanja odpravile ali zmanjšale, kar kaže na delno reverzibilnost.
English: Gather your supplies for the injection and place them on a clean flat surface.
Slovenian: Zberite pripomočke za injekcijo in jih položite na čisto, ravno površino.